PROCURE Québec Prostate Cancer Biobank, Canada

Certification Status: Approved
Registration Status: Completed

Objective: PROCURE has initiated a Prostate cancer Biobank containing biospecimens, coupled to both clinico-pathological and epidemiologic data. This Biobank results from collaboration of urologists, scientists, pathologists and research personnel from four university hospitals in Québec province. Newly diagnosed patients undergoing radical prostatectomy agreed to sign an ethically approved consent form to participate in the project and responded to a detailed questionnaire on socio-demographic data and lifestyle habits. Blood, urine, and prostate tissues are obtained, systematically processed in a timely fashion and banked on site using standardized operating procedures. Blood, urine and clinical data are also collected at follow-up visits. At the end of 2012, the Biobank comprises more than 2 000 participants and had registered more than 2400 follow-up visits.

Registered Biobank Name PROCURE Québec Prostate Cancer Biobank
Biobank Leader Valérie Thibodeau
Country Canada
Email for biobank inquiries valerie.thibodeau@procure.ca
Principal Investigator Dr Armen Aprikian, Dr Fred Saad, Dr Michel Carmel, Dr Louis Lacombe
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.
Biospecimen Collected: